{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:57:20Z","timestamp":1793105840403,"version":"4.5.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41391-025-01061-9","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:09:42Z","timestamp":1764918582000},"page":"503-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Infection risks and biopsy-associated complications in prostate cancer diagnosis: a review of recent literatures"],"prefix":"10.1038","volume":"29","author":[{"given":"Pavlov Valentin","family":"Nikolaevich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinyemi Olalekan","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmantsev Marat","family":"Fayazovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0746-8552","authenticated-orcid":false,"given":"Victor Olamiposi","family":"Olaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fagbemi Adeleke","family":"Adesegun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"1061_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/WJON1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10:63. https:\/\/doi.org\/10.14740\/WJON1191.","journal-title":"World J Oncol"},{"key":"1061_CR2","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0022-5347(01)62255-9","volume":"160","author":"LV Rodriguez","year":"1998","unstructured":"Rodriguez LV, Terris MK, RISKS AND. Complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol. 1998;160:2115\u201320. https:\/\/doi.org\/10.1016\/S0022-5347(01)62255-9.","journal-title":"J Urol"},{"key":"1061_CR3","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/JAMA.2017.7248","volume":"317","author":"MS Litwin","year":"2017","unstructured":"Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer: a review. JAMA. 2017;317:2532\u201342. https:\/\/doi.org\/10.1001\/JAMA.2017.7248.","journal-title":"JAMA"},{"key":"1061_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3109\/00365596709133542","volume":"1","author":"L Andersson","year":"1967","unstructured":"Andersson L, J\u00f6nsson G, Brunk U. Puncture biopsy of the prostate in the diagnosis of prostatic cancer. Scand J Urol Nephrol. 1967;1:227\u201334. https:\/\/doi.org\/10.3109\/00365596709133542.","journal-title":"Scand J Urol Nephrol"},{"key":"1061_CR5","doi-asserted-by":"publisher","unstructured":"Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;2013. https:\/\/doi.org\/10.1002\/14651858.CD004720.PUB3\/INFORMATION\/EN.","DOI":"10.1002\/14651858.CD004720.PUB3\/INFORMATION\/EN"},{"key":"1061_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/S00345-004-0420-1\/METRICS","volume":"22","author":"I Romics","year":"2004","unstructured":"Romics I. The technique of ultrasound guided prostate biopsy. World J Urol. 2004;22:353\u20136. https:\/\/doi.org\/10.1007\/S00345-004-0420-1\/METRICS.","journal-title":"World J Urol"},{"key":"1061_CR7","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.21037\/TAU.2019.09.37","volume":"9","author":"A Moe","year":"2020","unstructured":"Moe A, Hayne D. Transrectal ultrasound biopsy of the prostate: does it still have a role in prostate cancer diagnosis?. Transl Androl Urol. 2020;9:3018. https:\/\/doi.org\/10.21037\/TAU.2019.09.37.","journal-title":"Transl Androl Urol"},{"key":"1061_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/J.1445-2197.2005.03284.X","volume":"75","author":"J Miller","year":"2005","unstructured":"Miller J, Perumalla C, Heap G. Complications of transrectal versus transperineal prostate biopsy. ANZ J Surg. 2005;75:48\u201350. https:\/\/doi.org\/10.1111\/J.1445-2197.2005.03284.X.","journal-title":"ANZ J Surg"},{"key":"1061_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/S00261-003-0089-8\/METRICS","volume":"29","author":"MJ O\u2019Connell","year":"2004","unstructured":"O\u2019Connell MJ, Smith CS, Fitzpatrick PE, Keane CO, Fitzpatrick JM, Behan M, et al. Transrectal ultrasound-guided biopsy of the prostate gland: value of 12 versus 6 cores. Abdom Imaging. 2004;29:132\u20136. https:\/\/doi.org\/10.1007\/S00261-003-0089-8\/METRICS.","journal-title":"Abdom Imaging"},{"key":"1061_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/S13244-022-01210-X","volume":"13","author":"J Power","year":"2022","unstructured":"Power J, Murphy M, Hutchinson B, Murphy D, McNicholas M, O\u2019Malley K, et al. Transperineal ultrasound-guided prostate biopsy: what the radiologist needs to know. Insights Imaging. 2022;13:77. https:\/\/doi.org\/10.1186\/S13244-022-01210-X.","journal-title":"Insights Imaging"},{"key":"1061_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/IDR.S96163","volume":"9","author":"DD Lu","year":"2016","unstructured":"Lu DD, Raman JD. Strategies for prevention of ultrasound-guided prostate biopsy infections. Infect Drug Resist. 2016;9:161. https:\/\/doi.org\/10.2147\/IDR.S96163.","journal-title":"Infect Drug Resist"},{"key":"1061_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3909\/RIU0713","volume":"18","author":"JT Walker","year":"2016","unstructured":"Walker JT, Singla N, Roehrborn CG. Reducing infectious complications following transrectal ultrasound-guided prostate biopsy: a systematic review. Rev Urol. 2016;18:73. https:\/\/doi.org\/10.3909\/RIU0713.","journal-title":"Rev Urol"},{"key":"1061_CR13","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/S00345-020-03112-3\/METRICS","volume":"38","author":"O Derin","year":"2020","unstructured":"Derin O, Fonseca L, Sanchez-Salas R, Roberts MJ. Infectious complications of prostate biopsy: winning battles but not war. World J Urol. 2020;38:2743\u201353. https:\/\/doi.org\/10.1007\/S00345-020-03112-3\/METRICS.","journal-title":"World J Urol"},{"key":"1061_CR14","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/J.JURO.2010.11.088","volume":"185","author":"MA Liss","year":"2011","unstructured":"Liss MA, Chang A, Santos R, Nakama-Peeples A, Peterson EM, Osann K, et al. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol. 2011;185:1283\u20138. https:\/\/doi.org\/10.1016\/J.JURO.2010.11.088.","journal-title":"J Urol"},{"key":"1061_CR15","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.21037\/TAU.2019.12.40","volume":"9","author":"A Thomson","year":"2020","unstructured":"Thomson A, Li M, Grummet J, Sengupta S. Transperineal prostate biopsy: a review of technique. Transl Androl Urol. 2020;9:3009. https:\/\/doi.org\/10.21037\/TAU.2019.12.40.","journal-title":"Transl Androl Urol"},{"key":"1061_CR16","doi-asserted-by":"publisher","first-page":"E69","DOI":"10.1111\/J.1464-410X.2011.10759.X","volume":"110","author":"M Dimmen","year":"2012","unstructured":"Dimmen M, Vlatkovic L, Hole KH, Nesland JM, Brennhovd B, Axcrona K. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. BJU Int. 2012;110:E69\u201375. https:\/\/doi.org\/10.1111\/J.1464-410X.2011.10759.X.","journal-title":"BJU Int"},{"key":"1061_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/J.1464-410X.2011.10355.X","volume":"109","author":"RP Pal","year":"2012","unstructured":"Pal RP, Elmussareh M, Chanawani M, Khan MA. The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies. BJU Int. 2012;109:367\u201371. https:\/\/doi.org\/10.1111\/J.1464-410X.2011.10355.X.","journal-title":"BJU Int"},{"key":"1061_CR18","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.5152\/TUD.2020.20358","volume":"47","author":"G Ortner","year":"2020","unstructured":"Ortner G, Tzanaki E, Rai BP, Nagele U, Tokas T. Transperineal prostate biopsy: the modern gold standard to prostate cancer diagnosis. Turk J Urol. 2020;47:S19. https:\/\/doi.org\/10.5152\/TUD.2020.20358.","journal-title":"Turk J Urol"},{"key":"1061_CR19","doi-asserted-by":"publisher","unstructured":"Sahu M, Wijesekera N, Donohue JF. Anterior prostate cancer: Current perspectives and diagnostic dilemmas. 2016;10:49\u201355. https:\/\/doi.org\/10.1177\/2051415816655724.","DOI":"10.1177\/2051415816655724"},{"key":"1061_CR20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/JU.0000000000000156","volume":"201","author":"V Stefanova","year":"2019","unstructured":"Stefanova V, Buckley R, Flax S, Spevack L, Hajek D, Tunis A, et al. Transperineal prostate biopsies using local anesthesia: experience with 1,287 patients. prostate cancer detection rate, complications and patient tolerability. J Urol. 2019;201:1121\u20135. https:\/\/doi.org\/10.1097\/JU.0000000000000156.","journal-title":"J Urol"},{"key":"1061_CR21","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/J.UROLOGY.2013.02.019","volume":"81","author":"P Pepe","year":"2013","unstructured":"Pepe P, Aragona F. Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology. 2013;81:1142\u20136. https:\/\/doi.org\/10.1016\/J.UROLOGY.2013.02.019.","journal-title":"Urology"},{"key":"1061_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/J.EURURO.2015.06.005","volume":"69","author":"X Meng","year":"2016","unstructured":"Meng X, Rosenkrantz AB, Mendhiratta N, Fenstermaker M, Huang R, Wysock JS, et al. Relationship between prebiopsy multiparametric magnetic resonance imaging (MRI), biopsy indication, and MRI-ultrasound fusion\u2013targeted prostate biopsy outcomes. Eur Urol. 2016;69:512\u20137. https:\/\/doi.org\/10.1016\/J.EURURO.2015.06.005.","journal-title":"Eur Urol"},{"key":"1061_CR23","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/J.EUO.2020.12.012","volume":"4","author":"BP Rai","year":"2021","unstructured":"Rai BP, Mayerhofer C, Somani BK, Kallidonis P, Nagele U, Tokas T. Magnetic Resonance Imaging\/Ultrasound Fusion-guided Transperineal Versus Magnetic Resonance Imaging\/Ultrasound Fusion-guided Transrectal Prostate Biopsy-A Systematic Review. Eur. Urol Oncol. 2021;4:904\u201313. https:\/\/doi.org\/10.1016\/J.EUO.2020.12.012.","journal-title":"Urol Oncol"},{"key":"1061_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/J.EURURO.2018.11.023","volume":"75","author":"M van der Leest","year":"2019","unstructured":"van der Leest M, Cornel E, Isra\u00ebl B, Hendriks R, Padhani AR, Hoogenboom M, et al. Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-na\u00efve men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol. 2019;75:570\u20138. https:\/\/doi.org\/10.1016\/J.EURURO.2018.11.023.","journal-title":"Eur Urol"},{"key":"1061_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.4236\/OJU.2023.1310048","volume":"13","author":"JBM Mekeme","year":"2023","unstructured":"Mekeme JBM, Mbouche OL, Bello F, Awondo BC, Mbassi AA, Fouda CJ, et al. Comparison of transrectal prostate digital and ultrasound-guided core biopsies in 400 men in a low-and-middle income country. Open J Urol. 2023;13:418\u201332. https:\/\/doi.org\/10.4236\/OJU.2023.1310048.","journal-title":"Open J Urol"},{"key":"1061_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/S41669-021-00277-4\/FIGURES\/4","volume":"5","author":"ECF Wilson","year":"2021","unstructured":"Wilson ECF, Wreford A, Tamer P, Leonard K, Brechka H, Gnanapragasam VJ. Economic evaluation of transperineal versus transrectal devices for local anaesthetic prostate biopsies. Pharmacoecon Open. 2021;5:737\u201353. https:\/\/doi.org\/10.1007\/S41669-021-00277-4\/FIGURES\/4.","journal-title":"Pharmacoecon Open"},{"key":"1061_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/J.PRNIL.2023.11.003","volume":"12","author":"Y Chung","year":"2023","unstructured":"Chung Y, Hong SK. Shifting to transperineal prostate biopsy: a narrative review. Prostate Int. 2023;12:10. https:\/\/doi.org\/10.1016\/J.PRNIL.2023.11.003.","journal-title":"Prostate Int"},{"key":"1061_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/BJU.15062","volume":"126","author":"AS Tamhankar","year":"2020","unstructured":"Tamhankar AS, El-Taji O, Vasdev N, Foley C, Popert R, Adshead J. The clinical and financial implications of a decade of prostate biopsies in the NHS: analysis of Hospital Episode Statistics data 2008\u20132019. BJU Int. 2020;126:133\u201341. https:\/\/doi.org\/10.1111\/BJU.15062.","journal-title":"BJU Int"},{"key":"1061_CR29","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/J.EURURO.2013.05.049","volume":"64","author":"S Loeb","year":"2013","unstructured":"Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64:876\u201392. https:\/\/doi.org\/10.1016\/J.EURURO.2013.05.049.","journal-title":"Eur Urol"},{"key":"1061_CR30","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/CID\/CIAC913","volume":"76","author":"SCM Tops","year":"2023","unstructured":"Tops SCM, Kolwijck E, Koldewijn EL, Somford DM, Delaere FJM, van Leeuwen MA, et al. Rectal culture-based versus empirical antibiotic prophylaxis to prevent infectious complications in men undergoing transrectal prostate biopsy: a randomized, nonblinded multicenter trial. Clin Infect Dis. 2023;76:1188\u201396. https:\/\/doi.org\/10.1093\/CID\/CIAC913.","journal-title":"Clin Infect Dis"},{"key":"1061_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/BJU.14198","volume":"122","author":"J Knaapila","year":"2018","unstructured":"Knaapila J, Kallio H, Hakanen AJ, Syv\u00e4nen K, Ettala O, K\u00e4hk\u00f6nen E, et al. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study. BJU Int. 2018;122:203\u201310. https:\/\/doi.org\/10.1111\/BJU.14198.","journal-title":"BJU Int"},{"key":"1061_CR32","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/S00345-016-1800-Z","volume":"34","author":"M Samarinas","year":"2016","unstructured":"Samarinas M, Dimitropoulos K, Zachos I, Gravas S, Karatzas A, Tzortzis V. A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance. World J Urol. 2016;34:1555\u20139. https:\/\/doi.org\/10.1007\/S00345-016-1800-Z.","journal-title":"World J Urol"},{"key":"1061_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/S00345-019-02837-0","volume":"38","author":"TEB Johansen","year":"2020","unstructured":"Johansen TEB, Zahl PH, Baco E, Bartoletti R, Bonkat G, Bruyere F, et al. Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry. World J Urol. 2020;38:17\u201326. https:\/\/doi.org\/10.1007\/S00345-019-02837-0.","journal-title":"World J Urol"},{"key":"1061_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/1008-682X.173453","volume":"19","author":"K Wadhwa","year":"2017","unstructured":"Wadhwa K, Carmona-Echeveria L, Kuru T, Gaziev G, Serrao E, Parashar D, et al. Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures. Asian J Androl. 2017;19:62\u20136. https:\/\/doi.org\/10.4103\/1008-682X.173453.","journal-title":"Asian J Androl"},{"key":"1061_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/CU9.0000000000000013","volume":"15","author":"A Al-Mitwalli","year":"2021","unstructured":"Al-Mitwalli A, Kyriazis G, El-Taji O, Chandra E, Deborah W, Burns P, et al. Selective transperineal prostate biopsy for fluoroquinolone-resistance patients reduces sepsis and cost. Curr Urol. 2021;15:115. https:\/\/doi.org\/10.1097\/CU9.0000000000000013.","journal-title":"Curr Urol"},{"key":"1061_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/S41391-021-00423-3","volume":"25","author":"T Kohl","year":"2021","unstructured":"Kohl T, Sigle A, Kuru T, Salem J, Rolfs H, Kowalke T, et al. Comprehensive analysis of complications after transperineal prostate biopsy without antibiotic prophylaxis: results of a multicenter trial with 30 days\u2019 follow-up. Prostate Cancer Prostatic Dis. 2021;25:264. https:\/\/doi.org\/10.1038\/S41391-021-00423-3.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1061_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/IJU.IJU-222-21","volume":"38","author":"A Sivaraman","year":"2022","unstructured":"Sivaraman A, Ramasamy V, Aarthy P, Sankar V, Sivaraman PB. Safety and feasibility of freehand transperineal prostate biopsy under local anesthesia: Our initial experience. Indian J Urol. 2022;38:34\u201341. https:\/\/doi.org\/10.4103\/IJU.IJU-222-21.","journal-title":"Indian J Urol"},{"key":"1061_CR38","doi-asserted-by":"publisher","first-page":"100247","DOI":"10.1016\/J.INFPIP.2022.100247","volume":"4","author":"C Lenihan","year":"2022","unstructured":"Lenihan C, Daly E, Bernard M, Murphy C, Lauhoff S, Power M, et al. Introduction of surgical site surveillance post transrectal ultrasound (TRUS) guided prostate biopsy and the impact on infection rates. Infect Prev Pr. 2022;4:100247. https:\/\/doi.org\/10.1016\/J.INFPIP.2022.100247.","journal-title":"Infect Prev Pr"},{"key":"1061_CR39","doi-asserted-by":"publisher","first-page":"860","DOI":"10.15537\/SMJ.2016.8.15803","volume":"37","author":"SS Alkhateeb","year":"2016","unstructured":"Alkhateeb SS, Alshammari NA, Alzughaibi MA, Ghazwani YG, Alrabeeah KA, Albqami NM. The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones. Saudi Med J. 2016;37:860\u20133. https:\/\/doi.org\/10.15537\/SMJ.2016.8.15803.","journal-title":"Saudi Med J"},{"key":"1061_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1590\/S1677-5538.IBJU.2014.0607","volume":"42","author":"M Shahait","year":"2016","unstructured":"Shahait M, Degheili J, El-Merhi F, Tamim H, Nasr R. Incidence of sepsis following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon. Int Braz J Urol: J Braz Soc Urol. 2016;42:60. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2014.0607.","journal-title":"Int Braz J Urol: J Braz Soc Urol"},{"key":"1061_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/ANTIBIOTICS11030415","volume":"11","author":"G Tulone","year":"2022","unstructured":"Tulone G, Giannone S, Mannone P, Tognarelli A, Di Vico T, Giaimo R, et al. Comparison of fluoroquinolones and other antibiotic prophylaxis regimens for preventing complications in patients undergoing transrectal prostate biopsy. Antibiotics. 2022;11:415. https:\/\/doi.org\/10.3390\/ANTIBIOTICS11030415.","journal-title":"Antibiotics"},{"key":"1061_CR42","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/S10096-016-2742-5","volume":"35","author":"LD Qiao","year":"2016","unstructured":"Qiao LD, Chen S, Wang XF, Yang WM, Niu YJ, Kong CZ, et al. A multi-center, controlled, randomized, open-label clinical study of levofloxacin for preventing infection during the perioperative period of ultrasound-guided transrectal prostate biopsy. Eur J Clin Microbiol Infect Dis. 2016;35:1877. https:\/\/doi.org\/10.1007\/S10096-016-2742-5.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1061_CR43","doi-asserted-by":"publisher","unstructured":"Zembower TR, Maxwell KM, Nadler RB, Cashy J, Scheetz MH, Qi C, et al. Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: A prospective cohort trial. BMC Infect Dis 2017;17. https:\/\/doi.org\/10.1186\/S12879-017-2470-1.","DOI":"10.1186\/S12879-017-2470-1"},{"key":"1061_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4111\/ICU.2017.58.5.365","volume":"58","author":"P Singh","year":"2017","unstructured":"Singh P, Kumar A, Yadav S, Prakash L, Nayak B, Kumar R, et al. \u201cTargeted\u201d prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy. Investig Clin Urol. 2017;58:365. https:\/\/doi.org\/10.4111\/ICU.2017.58.5.365.","journal-title":"Investig Clin Urol"},{"key":"1061_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/03915603241273888","author":"T \u00c7etin","year":"2024","unstructured":"\u00c7etin T, Yal\u00e7\u0131n MY, \u00d6zbilen MH, Cesur G, Bildirici \u00c7, Karaca E, et al. Saline cleansing can prevent infective complications after transrectal prostate biopsy: A randomized prospective study. Urologia J. 2024. https:\/\/doi.org\/10.1177\/03915603241273888.","journal-title":"Urologia J"},{"key":"1061_CR46","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1007\/S00345-021-03674-W","volume":"39","author":"RS Steinberg","year":"2021","unstructured":"Steinberg RS, Kipling L, Bens KCB, Patil D, Henry M, Mehta A, et al. Enhanced antibiotic prophylaxis and infection-related complications following prostate biopsy. World J Urol. 2021;39:3415. https:\/\/doi.org\/10.1007\/S00345-021-03674-W.","journal-title":"World J Urol"},{"key":"1061_CR47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4081\/AIUA.2022.2.155","volume":"94","author":"P Pepe","year":"2022","unstructured":"Pepe P, Pennisi M. Morbidity following transperineal prostate biopsy: our experience in 8.500 men. Archivio Italiano Di Urologia e. Andrologia. 2022;94:155\u20139. https:\/\/doi.org\/10.4081\/AIUA.2022.2.155.","journal-title":"Andrologia"},{"key":"1061_CR48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/J.JURO.2018.03.078","volume":"200","author":"P Jiang","year":"2018","unstructured":"Jiang P, Liss MA, Szabo RJ. Targeted antimicrobial prophylaxis does not always prevent sepsis after transrectal prostate biopsy. J Urol. 2018;200:361\u20138. https:\/\/doi.org\/10.1016\/J.JURO.2018.03.078.","journal-title":"J Urol"},{"key":"1061_CR49","doi-asserted-by":"publisher","unstructured":"Lu J, Elmarsafi T, Lakhiani C, Sher SR, Attinger C, Evans KK. Septic shock following prostate biopsy: aggressive limb salvage for extremities after pressor-induced ischemic gangrene. Plast Reconstr Surg Glob Open. 2017;5. https:\/\/doi.org\/10.1097\/GOX.0000000000001430.","DOI":"10.1097\/GOX.0000000000001430"},{"key":"1061_CR50","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/IJU.13883","volume":"26","author":"J Van Besien","year":"2019","unstructured":"Van Besien J, Uvin P, Weyne E, Van Praet C, Merckx L, De Graeve N, et al. Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: a prospective randomized study. Int J Urol. 2019;26:391\u20137. https:\/\/doi.org\/10.1111\/IJU.13883.","journal-title":"Int J Urol"},{"key":"1061_CR51","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1590\/S1677-5538.IBJU.2016.0619","volume":"43","author":"E Kisa","year":"2017","unstructured":"Kisa E, Altug MU, Gurbuz OA, Ozdemir H. Fosfomycin: a good alternative drug for prostate biopsy prophylaxis the results of a prospective, randomized trial with respect to risk factors. Int Braz J Urol. 2017;43:1068\u201374. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2016.0619.","journal-title":"Int Braz J Urol"},{"key":"1061_CR52","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/S11255-024-03998-7","volume":"56","author":"A Bouzouita","year":"2024","unstructured":"Bouzouita A, Rehaiem A, Saadi A, Zaghbib S, Chakroun M, Ayed H, et al. Antimicrobial prophylaxis protocol based on rectal swab culture before prostate biopsy to prevent infectious complications: a prospective randomized comparative study. Int Urol Nephrol. 2024;56:2495\u2013502. https:\/\/doi.org\/10.1007\/S11255-024-03998-7.","journal-title":"Int Urol Nephrol"},{"key":"1061_CR53","doi-asserted-by":"publisher","first-page":"660","DOI":"10.4111\/KJU.2014.55.10.660","volume":"55","author":"JW Choi","year":"2014","unstructured":"Choi JW, Kim TH, Chang IH, Kim K, Do Moon YT, Myung SC, et al. Febrile urinary tract infection after prostate biopsy and quinolone resistance. Korean J Urol. 2014;55:660\u20134. https:\/\/doi.org\/10.4111\/KJU.2014.55.10.660.","journal-title":"Korean J Urol"},{"key":"1061_CR54","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2147\/IDR.S171162","volume":"11","author":"YP Wu","year":"2018","unstructured":"Wu YP, Li XD. Ke Z Bin, Chen SH, Chen PZ, Wei Y, et al. Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy. Infect Drug Resist. 2018;11:1491. https:\/\/doi.org\/10.2147\/IDR.S171162.","journal-title":"Infect Drug Resist"},{"key":"1061_CR55","doi-asserted-by":"publisher","unstructured":"Nam W, Park MU, Chae HK, Song J, Kim HG, Park JY, et al. Recent trends in prostate biopsy complication rates and the role of aztreonam in periprocedural antimicrobial prophylaxis\u2014a nationwide population-based study from Korea. Antibiotics. 2022;11. https:\/\/doi.org\/10.3390\/ANTIBIOTICS11030312.","DOI":"10.3390\/ANTIBIOTICS11030312"},{"key":"1061_CR56","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/AAM.AAM-48-18","volume":"18","author":"A Doherty","year":"2019","unstructured":"Doherty A, Ikuerowo S, Jeje E, Ibrahim N, Ojongbede O, Mutiu W, et al. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy. Ann Afr Med. 2019;18:132\u20137. https:\/\/doi.org\/10.4103\/AAM.AAM-48-18.","journal-title":"Ann Afr Med"},{"key":"1061_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/J.PRNIL.2021.11.001","volume":"10","author":"GM Pirola","year":"2022","unstructured":"Pirola GM, Gubbiotti M, Rubilotta E, Castellani D, Trabacchin N, Tafuri A, et al. Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study. Prostate Int. 2022;10:34\u20137. https:\/\/doi.org\/10.1016\/J.PRNIL.2021.11.001.","journal-title":"Prostate Int"},{"key":"1061_CR58","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2147\/RRU.S333724","volume":"13","author":"Y Tohi","year":"2021","unstructured":"Tohi Y, Fujiwara K, Harada S, Matsuda I, Ito A, Yamasaki M, et al. Positive culture prior to transperineal prostate biopsy was not associated with post-biopsy febrile urinary tract infection development. Res Rep Urol. 2021;13:691. https:\/\/doi.org\/10.2147\/RRU.S333724.","journal-title":"Res Rep Urol"},{"key":"1061_CR59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/IJU.IJU_222_21","volume":"38","author":"A Sivaraman","year":"2022","unstructured":"Sivaraman A, Ramasamy V, Aarthy P, Sankar V, Sivaraman PB. Safety and feasibility of freehand transperineal prostate biopsy under local anesthesia: Our initial experience. Indian. J Urol. 2022;38:34\u201341. https:\/\/doi.org\/10.4103\/IJU.IJU_222_21.","journal-title":"J Urol"},{"key":"1061_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1590\/S1677-5538.IBJU.2015.01.08","volume":"41","author":"RC Chamb\u00f3","year":"2015","unstructured":"Chamb\u00f3 RC, Tsuji FH, Yamamoto HA, de Jesus CMN. Short-term prophylaxis with ciprofloxacin in extended 16- core prostate biopsy. Int Braz J Urol. 2015;41:46\u201353. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2015.01.08.","journal-title":"Int Braz J Urol"},{"key":"1061_CR61","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/J.IJTB.2015.07.014","volume":"63","author":"CH Chen","year":"2016","unstructured":"Chen CH, Lin J, Lin JS, Chen YM. Mycobacterium abscessus complex bacteremia due to prostatitis after prostate biopsy. Indian J Tuberculosis. 2016;63:273\u20135. https:\/\/doi.org\/10.1016\/J.IJTB.2015.07.014.","journal-title":"Indian J Tuberculosis"},{"key":"1061_CR62","doi-asserted-by":"publisher","unstructured":"Tay JYI, McGrath S, Perera M, Anderson P. Chronic bacterial prostatitis leading to intrascrotal abscess after transperineal prostate biopsy. BMJ Case Rep. 2021;14. https:\/\/doi.org\/10.1136\/BCR-2020-239277.","DOI":"10.1136\/BCR-2020-239277"},{"key":"1061_CR63","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5152\/TUD.2019.19172","volume":"46","author":"B Ergani","year":"2020","unstructured":"Ergani B, \u00c7etin T, Yal\u00e7\u0131n MY, \u00d6zbilen MH, Bildirici \u00c7, Karaca E, et al. Effect of rectal mucosa cleansing on acute prostatitis during prostate biopsy: a randomized prospective study. Turk J Urol. 2020;46:159\u201364. https:\/\/doi.org\/10.5152\/TUD.2019.19172.","journal-title":"Turk J Urol"},{"key":"1061_CR64","doi-asserted-by":"publisher","unstructured":"Boeri L, Fontana M, Gallioli A, Zanetti SP, Catellani M, Longo F, et al. Rectal culture-guided targeted antimicrobial prophylaxis reduces the incidence of post-operative infectious complications in men at high risk for infections submitted to transrectal ultrasound prostate biopsy -results of a cross-sectional study. PLoS One. 2017;12. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0170319.","DOI":"10.1371\/JOURNAL.PONE.0170319"},{"key":"1061_CR65","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4274\/UOB.GALENOS.2022.2021.11.2","volume":"21","author":"E Akg\u00fcne\u015f","year":"2022","unstructured":"Akg\u00fcne\u015f E, Ayd\u0131n M, G\u00f6rg\u00fcn S, G\u00fcnal \u00d6, Bitkin A, Kele\u015f M, et al. The evaluation of goal-directed antibiotics prophylaxis applied via rectal swab before transrectal ultrasound-guided prostate biopsy. Bull Urooncol. 2022;21:52\u20137. https:\/\/doi.org\/10.4274\/UOB.GALENOS.2022.2021.11.2.","journal-title":"Bull Urooncol"},{"key":"1061_CR66","doi-asserted-by":"publisher","unstructured":"Hamano I, Hatakeyama S, Yoneyama T, Tobisawa Y, Soma O, Matsumoto T, et al. Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents. Springerplus. 2016;5. https:\/\/doi.org\/10.1186\/S40064-016-3610-6.","DOI":"10.1186\/S40064-016-3610-6"},{"key":"1061_CR67","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/ANS.17593","volume":"92","author":"A Hong","year":"2022","unstructured":"Hong A, Hemmingway S, Wetherell D, Dias B, Zargar H. Outpatient transperineal prostate biopsy under local anaesthesia is safe, well tolerated and feasible. ANZ J Surg. 2022;92:1480. https:\/\/doi.org\/10.1111\/ANS.17593.","journal-title":"ANZ J Surg"},{"key":"1061_CR68","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000358494","volume":"93","author":"P Pepe","year":"2014","unstructured":"Pepe P, Dibenedetto G, Pennisi M, Fraggetta F, Colecchia M, Aragona F. Detection rate of anterior prostate cancer in 226 patients submitted to initial and repeat transperineal biopsy. Urol Int. 2014;93:189\u201392. https:\/\/doi.org\/10.1159\/000358494.","journal-title":"Urol Int"},{"key":"1061_CR69","doi-asserted-by":"publisher","unstructured":"Walter M, Trotsenko P, Breit HC, Keller N, Meyer A, Winkel DJ, et al. Safety profile of robotic-assisted transperineal MRI-US-fusion guided biopsy of the prostate. Front Oncol. 2022;12. https:\/\/doi.org\/10.3389\/FONC.2022.1025355.","DOI":"10.3389\/FONC.2022.1025355"},{"key":"1061_CR70","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1148\/RADIOL.204066","volume":"303","author":"R Kumar","year":"2022","unstructured":"Kumar R, Singh SK, Mittal BR, Vadi SK, Kakkar N, Singh H, et al. Safety and diagnostic yield of 68Ga prostate-specific membrane antigen PET\/CT-guided robotic-assisted transgluteal prostatic biopsy. Radiology. 2022;303:392\u20138. https:\/\/doi.org\/10.1148\/RADIOL.204066.","journal-title":"Radiology"},{"key":"1061_CR71","doi-asserted-by":"publisher","unstructured":"Alberti A, Nicoletti R, Polverino P, Rivetti A, Dibilio E, Resta GR, et al. Morbidity of transrectal MRI-fusion targeted prostate biopsy at a tertiary referral academic centre: an audit to guide the transition to the transperineal approach. Cancers (Basel). 2023;15. https:\/\/doi.org\/10.3390\/CANCERS15245798.","DOI":"10.3390\/CANCERS15245798"},{"key":"1061_CR72","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/JU.0000000000003788","volume":"211","author":"BM Mian","year":"2024","unstructured":"Mian BM, Feustel PJ, Aziz A, Kaufman RP, Bernstein A, Avulova S, et al. Complications following transrectal and transperineal prostate biopsy: results of the ProBE-PC randomized clinical trial. J Urol. 2024;211:205\u201313. https:\/\/doi.org\/10.1097\/JU.0000000000003788.","journal-title":"J Urol"},{"key":"1061_CR73","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.eururo.2023.12.015","volume":"86","author":"JC Hu","year":"2024","unstructured":"Hu JC, Assel M, Allaf ME, Ehdaie B, Vickers AJ, Cohen AJ, et al. Transperineal versus transrectal magnetic resonance imaging\u2013targeted and systematic prostate biopsy to prevent infectious complications: the PREVENT randomized trial. Eur Urol. 2024;86:61\u20138. https:\/\/doi.org\/10.1016\/j.eururo.2023.12.015.","journal-title":"Eur Urol"},{"key":"1061_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/J.EUO.2024.01.019","author":"G Ploussard","year":"2024","unstructured":"Ploussard G, Barret E, Fiard G, Lenfant L, Malavaud B, Giannarini G, et al. Transperineal versus transrectal magnetic resonance imaging\u2013targeted biopsies for prostate cancer diagnosis: final results of the randomized PERFECT trial (CCAFU-PR1). Eur Urol Oncol. 2024. https:\/\/doi.org\/10.1016\/J.EUO.2024.01.019.","journal-title":"Eur Urol Oncol"},{"key":"1061_CR75","doi-asserted-by":"publisher","unstructured":"Tang G, Yang R, Sun J, Zhang F, Wu J, Zhao H. The role of freehand transperineal prostate biopsy under local anesthesia without antibiotics in outpatient settings. Am J Mens Health. 2024;18. https:\/\/doi.org\/10.1177\/15579883241302045.","DOI":"10.1177\/15579883241302045"},{"key":"1061_CR76","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/J.UROLOGY.2023.09.010","volume":"182","author":"JM Myrga","year":"2023","unstructured":"Myrga JM, Erpenbeck SP, Watts A, Stencel MG, Staniorski CJ, Patnaik S, et al. Patient reported outcomes of transperineal prostate biopsy with tumescent local anesthesia. Urology. 2023;182:33\u20139. https:\/\/doi.org\/10.1016\/J.UROLOGY.2023.09.010.","journal-title":"Urology"},{"key":"1061_CR77","doi-asserted-by":"publisher","unstructured":"Ueda N, Sato M, Mori S, Matsukawa A, Oki Y, Kujime Y, et al. Lower dose of 5\u2009mL of 1% lidocaine is more suitable than the conventional 10\u2009mL for caudal block in transrectal prostate biopsy: a retrospective cohort study. Adv Urol 2024;2024. https:\/\/doi.org\/10.1155\/2024\/9331738.","DOI":"10.1155\/2024\/9331738"},{"key":"1061_CR78","doi-asserted-by":"publisher","first-page":"140","DOI":"10.5173\/CEJU.2020.0075","volume":"73","author":"R Aslan","year":"2020","unstructured":"Aslan R, Erbin A, Eryilmaz R, Taken K. Comparative evaluation of bilateral pudendal nerve blockade and periprostatic nerve block in transrectal ultrasound guided prostate biopsy: a prospective randomised trial. Cent Eur J Urol. 2020;73:140\u20135. https:\/\/doi.org\/10.5173\/CEJU.2020.0075.","journal-title":"Cent Eur J Urol"},{"key":"1061_CR79","doi-asserted-by":"publisher","unstructured":"Hsieh PF, Chang TY, Lin WC, Chang H, Chang CH, Huang CP, et al. A comparative study of transperineal software-assisted magnetic resonance\/ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate. BMC Urol. 2022;22. https:\/\/doi.org\/10.1186\/S12894-022-01011-W.","DOI":"10.1186\/S12894-022-01011-W"},{"key":"1061_CR80","first-page":"312","volume":"11","author":"M Dadpour","year":"2023","unstructured":"Dadpour M, Soltani AM, Ghafoori M, Basiri A, Borumandnia N, Nayebzade A, et al. Ultrasound\/MRI-targeted biopsy versus saturated trans-rectal ultrasound guided biopsy of prostate in patients with primary negative conventional biopsy and still elevated PSA: a prospective randomized clinical trial. Am J Clin Exp Urol. 2023;11:312.","journal-title":"Am J Clin Exp Urol"},{"key":"1061_CR81","doi-asserted-by":"publisher","unstructured":"Tzeng M, Cricco-Lizza E, Al Hussein Al Awamlh B, Pantuck M, Margolis DJ, Yu M, et al. IDEAL Stage 2a experience with in-office, transperineal MRI\/ultrasound software fusion targeted prostate biopsy. BMJ Surg Interv Health Technol. 2019;1. https:\/\/doi.org\/10.1136\/BMJSIT-2019-000025.","DOI":"10.1136\/BMJSIT-2019-000025"},{"key":"1061_CR82","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1007\/S00330-018-5497-9","volume":"28","author":"CG Overduin","year":"2018","unstructured":"Overduin CG, Heidkamp J, Rothgang E, Barentsz JO, de Lange F, F\u00fctterer JJ. Fast 3-T MR-guided transrectal prostate biopsy using an in-room tablet device for needle guide alignment: a feasibility study. Eur Radio. 2018;28:4824. https:\/\/doi.org\/10.1007\/S00330-018-5497-9.","journal-title":"Eur Radio"},{"key":"1061_CR83","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1111\/ANS.17713","volume":"92","author":"MA Furrer","year":"2022","unstructured":"Furrer MA, Hong A, Wetherell D, Heinze SB, Simkin P, Chow K, et al. Evaluating the diagnostic role of in-bore magnetic resonance imaging guided prostate biopsy: a single-centre study. ANZ J Surg. 2022;92:1486\u201391. https:\/\/doi.org\/10.1111\/ANS.17713.","journal-title":"ANZ J Surg"},{"key":"1061_CR84","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/JMRI.24383","volume":"40","author":"AJ Jung","year":"2014","unstructured":"Jung AJ, Westphalen AC, Kurhanewicz J, Wang ZJ, Carroll PR, Simko JP, et al. Clinical utility of endorectal MRI-guided prostate biopsy: preliminary experience. J Magn Reson Imaging. 2014;40:314\u201323. https:\/\/doi.org\/10.1002\/JMRI.24383.","journal-title":"J Magn Reson Imaging"},{"key":"1061_CR85","doi-asserted-by":"publisher","unstructured":"Theivendrampillai S, Yang B, Little M, Blick C. Targeted augmented reality-guided transperineal prostate biopsies study: initial experience. Ther Adv Urol. 2024;16. https:\/\/doi.org\/10.1177\/17562872241232582.","DOI":"10.1177\/17562872241232582"},{"key":"1061_CR86","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/BJU.15590","volume":"130","author":"SA Setia","year":"2022","unstructured":"Setia SA, Smith J, Cendo D, Yoder J, Gorin MA, Allaway MJ, et al. Outcomes of freehand transperineal prostate biopsy with omission of antibiotic prophylaxis. BJU Int. 2022;130:54\u201361. https:\/\/doi.org\/10.1111\/BJU.15590.","journal-title":"BJU Int"},{"key":"1061_CR87","doi-asserted-by":"publisher","first-page":"ofv002","DOI":"10.1093\/OFID\/OFV002","volume":"2","author":"JR Johnson","year":"2015","unstructured":"Johnson JR, Polgreen PM, Beekmann SE. Transrectal prostate biopsy-associated prophylaxis and infectious complications: report of a query to the emerging infections network of the infectious diseases society of America. Open Forum Infect Dis. 2015;2:ofv002. https:\/\/doi.org\/10.1093\/OFID\/OFV002.","journal-title":"Open Forum Infect Dis"},{"key":"1061_CR88","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5173\/CEJU.2020.0067","volume":"73","author":"M Rafiq","year":"2020","unstructured":"Rafiq M, Farag F, Manley K, Ho E. Ciprofloxacin: single versus multiple doses in transrectal ultrasound guided prostate biopsy. Cent Eur J Urol. 2020;73:91. https:\/\/doi.org\/10.5173\/CEJU.2020.0067.","journal-title":"Cent Eur J Urol"},{"key":"1061_CR89","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4274\/BALKANMEDJ.2018.0477","volume":"35","author":"A Kalkanl\u0131","year":"2018","unstructured":"Kalkanl\u0131 A, Gezmi\u015f CT, \u00d6zkan A, \u00c7ilesiz NC, Yanaral F, Ayd\u0131n M, et al. Comparison of single and prolonged fluoroquinolone prophylaxis and risk factors for infectious complications after transrectal prostate biopsy. Balk Med J. 2018;35:373\u20137. https:\/\/doi.org\/10.4274\/BALKANMEDJ.2018.0477.","journal-title":"Balk Med J"},{"key":"1061_CR90","doi-asserted-by":"publisher","first-page":"875670","DOI":"10.1155\/2014\/875670","volume":"2014","author":"E Linden-Castro","year":"2014","unstructured":"Linden-Castro E, Pelayo-Nieto M, Alias-Melgar A, Rosa FC la. Single dose of levofloxacin versus three dosages for prophylaxis in prostate biopsy. Int Sch Res Not. 2014;2014:875670. https:\/\/doi.org\/10.1155\/2014\/875670.","journal-title":"Int Sch Res Not"},{"key":"1061_CR91","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4111\/ICU.2019.60.1.54","volume":"60","author":"M Farag","year":"2019","unstructured":"Farag M, Riddell S, Daffy J, Wong LM. Comparing infective complications from transrectal ultrasound guided prostate biopsy following transition to single dose oral ciprofloxacin prophylaxis. Investig Clin Urol. 2019;60:54\u201360. https:\/\/doi.org\/10.4111\/ICU.2019.60.1.54.","journal-title":"Investig Clin Urol"},{"key":"1061_CR92","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4111\/KJU.2015.56.6.466","volume":"56","author":"C Lee","year":"2015","unstructured":"Lee C, You D, Jeong IG, Hong JH, Choo MS, Ahn H, et al. Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy. Korean J Urol. 2015;56:466\u201372. https:\/\/doi.org\/10.4111\/KJU.2015.56.6.466.","journal-title":"Korean J Urol"},{"key":"1061_CR93","doi-asserted-by":"publisher","unstructured":"Thirion DJG, Caissy JA, Poulin F, Lanfranchi CSH, Deda A, Aprikian A, et al. Ciprofloxacin alone vs. ciprofloxacin plus an aminoglycoside for the prevention of infectious complications following a transrectal ultrasound-guided prostate biopsy: a retrospective cohort study. Antibiotics (Basel). 2022;12. https:\/\/doi.org\/10.3390\/ANTIBIOTICS12010056.","DOI":"10.3390\/ANTIBIOTICS12010056"},{"key":"1061_CR94","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/J.PRNIL.2021.03.001","volume":"9","author":"DG Lim","year":"2021","unstructured":"Lim DG, Jung SIL, Kim MS, Chung HS, Hwang EC, Kwon DD. Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora. Prostate Int. 2021;9:163\u20138. https:\/\/doi.org\/10.1016\/J.PRNIL.2021.03.001.","journal-title":"Prostate Int"},{"key":"1061_CR95","doi-asserted-by":"publisher","unstructured":"Albers P, Bennett J, Evans M, Martin ES, Broomfield S, Mart\u00edn AM, et al. Complication rates of ciprofloxacin alone vs. ciprofloxacin plus fosfomycin for transrectal prostate biopsy. Can Urol Assoc J. 2024;18. https:\/\/doi.org\/10.5489\/CUAJ.8532.","DOI":"10.5489\/CUAJ.8532"},{"key":"1061_CR96","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4111\/ICU.20220147","volume":"63","author":"SH Yu","year":"2022","unstructured":"Yu SH, Jung SIL, Ryu JW, Kim MS, Chung HS, Hwang EC, et al. Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study. Investig Clin Urol. 2022;63:663\u201370. https:\/\/doi.org\/10.4111\/ICU.20220147.","journal-title":"Investig Clin Urol"},{"key":"1061_CR97","doi-asserted-by":"publisher","unstructured":"Izadpanahi MH, Nouri-Mahdavi K, Majidi SM, Khorrami MH, Alizadeh F, Mohammadi-Sichani M. Addition of ceftriaxone and amikacin to a ciprofloxacin plus metronidazole regimen for preventing infectious complications of transrectal ultrasound-guided prostate biopsy: a randomized controlled trial. Adv Urol. 2017;2017. https:\/\/doi.org\/10.1155\/2017\/4635386.","DOI":"10.1155\/2017\/4635386"},{"key":"1061_CR98","doi-asserted-by":"publisher","unstructured":"Bovo A, Kwiatkowski M, Manka L, Wetterauer C, Fux CA, Cattaneo M, et al. Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim\/sulfamethoxazole for preventing infections after transrectal prostate biopsy. World J Urol. 2024;42. https:\/\/doi.org\/10.1007\/S00345-024-05048-4.","DOI":"10.1007\/S00345-024-05048-4"},{"key":"1061_CR99","doi-asserted-by":"publisher","first-page":"E863","DOI":"10.5489\/CUAJ.3068","volume":"9","author":"V Sen","year":"2015","unstructured":"Sen V, Aydogdu O, Bozkurt IH, Yonguc T, Sen P, Polat S, et al. The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: a prospective, randomized, and controlled clinical study. Can Urol Assoc J. 2015;9:E863\u20137. https:\/\/doi.org\/10.5489\/CUAJ.3068.","journal-title":"Can Urol Assoc J"},{"key":"1061_CR100","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/J.AJU.2016.05.003","volume":"14","author":"AM Fahmy","year":"2016","unstructured":"Fahmy AM, Kotb A, Youssif TA, Abdeldiam H, Algebaly O, Elabbady A. Fosfomycin antimicrobial prophylaxis for transrectal ultrasound-guided biopsy of the prostate: A prospective randomised study. Arab J Urol. 2016;14:228\u201333. https:\/\/doi.org\/10.1016\/J.AJU.2016.05.003.","journal-title":"Arab J Urol"},{"key":"1061_CR101","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/S00345-024-04969-4","volume":"42","author":"M Jahnen","year":"2024","unstructured":"Jahnen M, Amiel T, Kirchoff F, B\u00fcchler JW, Herkommer K, Rothe K, et al. Cotrimoxazole and targeted antibiotic prophylaxis for transrectal prostate biopsy: a single-center study. World J Urol. 2024;42:260. https:\/\/doi.org\/10.1007\/S00345-024-04969-4.","journal-title":"World J Urol"},{"key":"1061_CR102","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/PCAN.2016.70","volume":"20","author":"N Singla","year":"2017","unstructured":"Singla N, Walker J, Woldu SL, Passoni NM, De La Fuente K, Roehrborn CG. Formalin disinfection of prostate biopsy needles may reduce post-biopsy infectious complications. Prostate Cancer Prostatic Dis. 2017;20:216\u201320. https:\/\/doi.org\/10.1038\/PCAN.2016.70.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1061_CR103","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/S00345-019-02845-0","volume":"38","author":"P Recabal","year":"2020","unstructured":"Recabal P, Lee T, Vertosick E, Manasia M, Eastham J, Touijer K, et al. Quality improvement initiative to reduce variability and improve stewardship of antimicrobial prophylaxis for transrectal prostate needle biopsy. World J Urol. 2020;38:965\u201370. https:\/\/doi.org\/10.1007\/S00345-019-02845-0.","journal-title":"World J Urol"},{"key":"1061_CR104","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/S00345-022-04055-7","volume":"40","author":"R Bartoletti","year":"2022","unstructured":"Bartoletti R, Claps F, Tulone G, Perotti A, Zucchi A, Riccardi N, et al. Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study. World J Urol. 2022;40:2025\u201331. https:\/\/doi.org\/10.1007\/S00345-022-04055-7.","journal-title":"World J Urol"},{"key":"1061_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/S41391-024-00934-9","author":"I Wolff","year":"2025","unstructured":"Wolff I, B\u00fcchner M, Hauner K, Wagenlehner F, Burchardt M, Abele-Horn M, et al. Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis\u2014a systematic review including meta-analysis of all comparative studies. Prostate Cancer Prostatic Dis. 2025. https:\/\/doi.org\/10.1038\/S41391-024-00934-9.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1061_CR106","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer\u20142020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021;79:243\u201362. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.042.","journal-title":"Eur Urol"},{"key":"1061_CR107","doi-asserted-by":"publisher","unstructured":"Pepe P, Pepe L, Cignoli D, Roscigno M PSMA PET\/CT in the diagnosis of prostate cancer: Why and when? Archivio Italiano Di Urologia e Andrologia 2025;97. https:\/\/doi.org\/10.4081\/AIUA.2025.13746.","DOI":"10.4081\/AIUA.2025.13746"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01061-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01061-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01061-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T21:44:53Z","timestamp":1786657493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01061-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1038\/s41391-025-01061-9","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}